United States Biotechnology & Medical Research

Eikon Therapeutics Inc (EIKN)

Eikon Therapeutics recorded one notable purchase by Column Group IV GP, LP, totaling approximately 1.03 million dollars over the past ninety days. This acquisition occurred following a period where the stock price declined by 26.5 percent. No executive-level activity was observed, while the firm prepares for its upcoming November earnings report.
Ticker: EIKN
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Eikon Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Column Group IV GP, LP Large shareholder
Transaction date
Purchase
Price
463.09
Quantity 71,536 -10.9%
Value US$1,497,707
Column Group IV GP, LP Large shareholder
Transaction date
Purchase
Price
443.21
Quantity 56,127 +13.5%
Value US$111,780
Column Group IV GP, LP Large shareholder
Transaction date
Purchase
Price
305.64
Quantity 69,727 +27.1%
Value US$4,605,213
Column Group IV GP, LP Large shareholder
Transaction date
Purchase
Price
18.00
Quantity 1,437,323 +50.0%
Value US$25,871,814
2.9
FRAZIER KENNETH C Non-Executive Director
Transaction date
Purchase
Price
18.00
Quantity 111,111 New position
Value US$1,999,998
0.5
Wolfe Josh Non-Executive Director Large shareholder
Transaction date
Purchase
Price
18.00
Quantity 138,888 New position
Value US$2,499,984
0.5
Wolfe Josh Non-Executive Director Large shareholder
Transaction date
Purchase
Price
18.00
Quantity 138,888 New position
Value US$2,499,984
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-08 2026-09-03 B Purchase
Column Group IV GP, LP
Large shareholder
71,536 -10.9%
463.09
US$1,497,707 		71,536 -10.9% 463.09 US$1,497,707
2026-02-09 2026-02-06 B Purchase
Column Group IV GP, LP
Large shareholder
56,127 +13.5%
443.21
US$111,780 		56,127 +13.5% 443.21 US$111,780
2026-02-09 2026-02-06 B Purchase
Column Group IV GP, LP
Large shareholder
69,727 +27.1%
305.64
US$4,605,213 		69,727 +27.1% 305.64 US$4,605,213
2026-02-09 2026-02-06 B Purchase
Column Group IV GP, LP
Large shareholder
1,437,323 +50.0%
18.00
US$25,871,814 		1,437,323 +50.0% 18.00 US$25,871,814
2026-02-06 2026-02-04 B Purchase
2.1
Foresite Capital Management IV, LLC
Large shareholder
55,555 +4.4%
18.00
US$999,990 		55,555 +4.4% 18.00 US$999,990
2026-02-06 2026-02-04 B Purchase
2.9
FRAZIER KENNETH C
Non-Executive Director
111,111 New position
18.00
US$1,999,998 		111,111 New position 18.00 US$1,999,998
2026-02-06 2026-02-04 B Purchase
0.5
Lux Venture Partners V, LLC
Large shareholder
138,888 New position
18.00
US$2,499,984 		138,888 New position 18.00 US$2,499,984
2026-02-06 2026-02-04 B Purchase
0.5
Lux Venture Partners V, LLC
Large shareholder
138,888 New position
18.00
US$2,499,984 		138,888 New position 18.00 US$2,499,984
2026-02-06 2026-02-04 B Purchase
0.5
Wolfe Josh
Non-Executive Director Large shareholder
138,888 New position
18.00
US$2,499,984 		138,888 New position 18.00 US$2,499,984
2026-02-06 2026-02-04 B Purchase
0.5
Wolfe Josh
Non-Executive Director Large shareholder
138,888 New position
18.00
US$2,499,984 		138,888 New position 18.00 US$2,499,984
Explore more

More insider trading research around Eikon Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America